HOUSE_OVERSIGHT_024003 - HOUSE_OVERSIGHT_024116
nt New England 6 CONTROL NUMBER 257 - CONFIDENTIAL HOUSE_OVERSIGHT_024017 --- PAGE BREAK --- Journal of Medicine editorial (November 2013), where Janet Woodcock, MD, the FDA’s Director of the Center for Drug Evaluation and Research and other senior FDA staff members as co-authors, discussed the FDA’s new brea
Page: HOUSE_OVERSIGHT_024018 →No connected entities